chrisvoncsefalvay/vaers-outcomes huggingface dataset:
doesn't know if she has a fever as one minute it is saying one thing, she has a fever, and one saying another, she is low; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6207, expiration date was not reported), via an unspecified route of administration on 16Mar2021 (at the age of 58-years-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that on 19Mar2021 the patient doesn't know if she has a fever as one minute it is saying one thing, she has a fever, and one saying another, she is low. Patient, reporting on the Pfizer COVID vaccine, who explains she has a monitor to check her temperature and this morning when she woke up and checked it, it says she has a fever but she doesn't feel like she has a fever. Patient has a physical therapy appointment today and wants to know if she should go to the appointment. Patient got her first shot on 16Mar2021. This morning when she checked, the device she uses said she had temperature. She doesn't feel like she does though. It is noted that the information she was given says that a person could get a fever after the first shot. She is not going to go to the appointment, she doesn't want to take any chances. When asked the reading the device provided for her temperature she says it said 90-91 but then says she isn't sure, it said she had a fever. When asked to clarify the patient offers to recheck her temperature and then explains that it says low now, she remarks she doesn't know as the device is acting a fool. Consumer clarifies this statement saying she doesn't know if she has a fever as one minute it is saying one thing, she has a fever, and one saying another, she is reading a low temperature. Treatment: she just woke up to this, she hasn't done anything. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
I was healthy before the vaccine. 2 weeks after on the 23rd I had severe abdominal pain, heartburn and nausea. I ended up in the ER 4 times in 5 days and had an emergency Endoscopy. I tested negative for H. Pylori and they can't figure out why the inside of my stomach is so inflamed and red. I'm losing weight rapidly from the pain and I'm now on Carafate  4 times a day and Antacids twice a day with little to no relief still.. I've never had an issue with this before and it's really debilitating.
Patient sent message that he received a Tdap vaccine 5/17/17 at his routine physicial exam. He developed "mild fever, body aches, and on 5/19/17 a little bit of redness on back, chest, and arms". No change as of 5/22/17.
At time of vaccination there was an electric type pain that shot down my arm into my finger tips. Within two days of vaccine my arm began going numb and since of touch on the 3 middle fingers. Also, began developing rash on the right wrist. Went to Dermatologist about 3 weeks after rash and it took about 10 weeks. Went to ortho doctor and he was unable to do anything about numb arm. Arm has recovered about 80% but still experiences numbness.
Pt. rec'd vaccines 4/5/04 afternoon.  Mom states he began running high fever 4/7/04, doesn't know actually temp measurement (no thermometer).  Still running fever and crying 4/8/04 "as if he is in pain".  No other symptoms other than slight "heat rash" appearance to back on 4/6/04, gone by 4/7/04.  Mother is taking him to clinic today.
In 24 hrs pt had a red welt approx 3 ins long x 21 ins wide that was itching, burning and tender to touch.
t103.1R p/APAP given (3 tabs); @ 130 30mm x 30mm red swelling site of inject; s/s began @ 4AM on 7AUG91- s/s began 18 hrs p/inject; coryza s/s-chills & fever;
Pt felt nauseas and vomited x1. Pt given ice pack and water and reported feeling better.
Pain around my waist. Numbness from my thigh and going down to my ankle. Burning sensation around the front of my lower leg. Burning in my calf muscle. Extremely painful to walk. I went to a nerve and spine doctor around June 2021. I was prescribed Gabapentin and Cyclobenzaprine. I have been going to a physical therapist since August 2021.
Patient reports that she noticed right lower abdominal discomfort about 30 minutes after receiving the vaccine.   She decided to take Famotidine to try to relieve her discomfort.  She reports that the pain continued on and off for one week and continued as of Mon 9/27/21 at 3:34 PM.  Reports that the pain is a dull ache and feels like pain she had prior to getting her gallbladder removed.   Patient also reports persistent left anterior arm pain and difficulty raising arm over head and behind her back.   No swelling or redness.  No shoulder joint pain.   Reports that she feels that the arm pain and limitation in movement is about 50% better than it was at the onset. No history of left arm or shoulder problems.
Had brief sz; nl EEG; pneumocardiogram w/brief apneic episode assoc w/HR dec;
This spontaneous report as received from a healthcare worker, immunization coordinator refers to unspecified patients of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. Reporter stated that on unspecified dates since 01-JUL-2015, the patients were vaccinated with doses of (Oka/Merck) VARIVAX (dosing details were not reported) (lot # K007973 with an expiry date of 03-JUN-2016; K005178 with an expiry date of 10-APR-2016; K026385 with an expiry date of 15-DEC-2016), which have been exposed to temperatures outside of the recommended range. No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint. Additional information has been requested.
A consumer report has been received. The report concerns a 13 year old, male consumer who had been receiving nasal FLUMIST QUADRIVALENT started on an unknown date. The patient experienced stomach pains and diarrhea which started on 26-Oct-2014. The patient recovered from the event of stomach pains on an unspecified date and at the time of reporting, the event of diarrhea was improving. The report was considered to be non-serious.
itchy, watery eyes;spots in mouth;102 fever;body rash-onset 13MAR97;dx vaccine induced measles;
Patient's spouse called on 4-13-21 to cancel second dose appointment due to her husbands death on 4-9-21. Spouse states unsure of cause awaiting autopsy results. He received the vaccine on Wednesday 4-7-21 and his wife said he was fine that night and worked in the yard the following day in the morning and early afternoon. Thursday night/Friday morning she noticed he was thrashing in his sleep and making "weird sounds".
Tiredness; Headache; Joint pain of the knees.; Feeling unwell; Diarrhea; This is a spontaneous report from a contactable consumer. This 57-year-old female consumer reported for herself that: A 57-years-old female patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: HKEW0178), dose 2 via an unspecified route of administration on 19Jul2021 as DOSE 2, SINGLE for covid-19 immunisation.  The patient medical history was not reported. The historical vaccine includes bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: unknown), dose 1 via an unspecified route of administration on 28Jun2021 as DOSE 1, SINGLE for covid-19 immunisation. Concomitant medication(s) included trazodone (TRAZODONE) taken for an unspecified indication, start and stop date were not reported. On 26Jul2021, patient stated, she was having possible side effects from the Pfizer Vaccine. She got the second shot on 19Jul2021 and she was experiencing tiredness, headache, and joint pain of the knees, feeling unwell and diarrhea, no treatment received. Site of administration was pharmacy. The outcome of all events was unknown.   Follow-up (15Sep2021): Follow-up attempts are completed. No further information is expected.
18 X 14cm oval area of erythema, swelling, and warmth. Onset 22 August 2006.
Narrative: COVID infection following COVID vaccine series 03/05, Pfizer, dose #1 03/26, Pfizer, dose #2 08/16 COVID swab, result: detected 08/16 SARS-COV-2 LINEAGE result: B.1.617.2 08/16 SARS-COV-2 CLADE result: 21A 08/17 pt cc: cough, chills, fatigue, headache, myalgias, rhinorrhea exposure: unknown
Pt reported his left arm developed an itchy rash after the Prevnar. This was observed on L upper arm- red rash on 04/10/13 when pt came to clinic. Pt was recommended to continue Benadryl po.
Patient states she had a "raspy throat"  (itchiness not relieved with drinking water) about 35 minutes after vaccine. Two-three hours later, developed a slight wheeze and noticed the onset of a rash across chest, neck, and face; these symptoms last approximately 12 hours after receiving the shot. Symptoms continued through the following day and resolved within about 48 hours.
Started approx 80 minutes after injection with soft palate swelling and throat fullness, followed by change in voice, and chest tightness with paresthesias. Went directly to ED. Sats  were good, no wheeze, throat swelling was noted. BP initially 150/93, peaked at 189/93,. Was 148/67 at discharge. Received oral Benadryl and Zyrtec, IV dexamethasone and Pepcid. ECG was done, no other labs. Observed for approx 90 minutes with improvement of all symptoms. Did need to take additional Benadryl dose approx 5 hours after first dose for return of mild throat fullness and rising BP. Both resolved within 30 minutes of dose. No further throat symptoms, BP fluctuations for over 24 hours now
Red papule, (R) thigh - 3/9/08 (visit). Irregular red macules, papular rash R & L ankle - 3/11/08 (visit).  Wide circumferential urticarial rash arms  and (R) ankle - 3/17/08 (visit).
Patient received MODerna vaccien on 1/21/21 and 2/19/21. COVID positive 1/23/22. Presented to ER on 2/8/22. who presented with acute encephalopathy possibly sepsis versus metabolic.  Neurology consulted and EEG and MRI were negative.  LP was negative. Patient found to have E coli UTI for which she is on cefepime and vancomycin.  He was transferred to another HCF on 2/16/22 for higher level of care.
2 weeks after my booster I started experiencing a rash, that was very itchy and would swell up in welts.  it would come on quickly and be mainly on my core, chest, back stomach hip area.  It would go away quickly when i used benadryl cream.  I have been able to control with a childs benadryl every 36 hours.  and now after 6 weeks it is not as frequent but I do have flare ups that  I can stop with the cream. I did experience headache, body aches, chills, fever and fatigue with my 2nd Moderna dose and my booster dose.  After the first dose i did get a small red rash around the injection site after a week that went away in a day or 2
death J96.01 - Acute respiratory failure with hypoxia N17.9 - Acute kidney failure, unspecified K92.2 - Acute upper GI bleed K92.2 - Upper GI bleed
Immediately after injection, there was numbness on the left side of body, most notable in face/head. Observation area nurse flagged for problem and EMT took vitals and decided it was not a stroke. Told numbness is a known side effect and returned to office.
Patient reported lightheadedness immediately after vaccine given.  Transported to recliner via wheelchair.  BP reading 108/80, given PO fluids and symptoms resolved shortly after.   Assessed by the physician on site and cleared for release.
Inflammation, redness, pain progressing over 48 hours. Apparent cellulitis, responding only to IV nafcillin.
Patient was noted by parents to have extreme fussiness, inconsolable at times, low grade fever, fatigue and diarrhea 2 days after vaccines. Parents continue to note patient having intermittent periods of fussiness, short naps, and then sleeping more than normal when fussiness resolved. Patient was evaluated in office on 9/21/15 by PCP, started medication for reflux and discharged home. By end of week parents report continued intermittent fussiness, fatigue, difficult to wake, and when awake was dazed and lethargic. Patient was re-evaluated on 9/25/15, admitted to hospital for care. Patient developed staring episodes in hospital on 9/26/15, transferred to another hospital for further wup. Patient underwent several tests and procedures, diagnosed with seizures. Seizures have resolved with medication he is now taking.
Hypoxia on 9/24, but patient did have coronary artery disease with chest pain starting 8/6/21.
A mild local reaction; Mild induration; Urticaria; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (A mild local reaction), VACCINATION SITE INDURATION (Mild induration) and VACCINATION SITE URTICARIA (Urticaria) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (A mild local reaction), VACCINATION SITE INDURATION (Mild induration) and VACCINATION SITE URTICARIA (Urticaria). On 25-Jan-2021, VACCINATION SITE REACTION (A mild local reaction), VACCINATION SITE INDURATION (Mild induration) and VACCINATION SITE URTICARIA (Urticaria) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No specific follow-up information recorded.
Information has been received from a registered nurse concerning a patient (age and gender not reported) who on an unspecified date was vaccinated with 0.5 mL of Pneumovax 23 (Lot# 651373/0320F).  Subsequently, the patient developed cellulitis.  The patient sought unspecified medical attention.  At the time of this report, the outcome of the event was unknown.  A lot check of concern has been requested.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements of the regulatory agency and was released by the regulatory agency.  Additional information has been requested.
29 YEAR OLD FEMALE WITH A HISTORY OF PENICILLIN ALLERGY, HAD COMPLAINT OF CHEST TIGHTNESS AFTER VACCINE GIVEN. ON SITE EMS RESPONDED. GAVE HER BENADRYL 25MG CAPSULE. SUGGESTED SHE GO TO ER IF SYMPTOMS PERSIST. SHE REFUSED AND WENT HOM. LUNGS WERE CLEAR, NO HISTORY OF HEALTH ISSUES
My COVID vaccine was first, followed by the influenza vaccine. Within minutes, I began to feel a warm unpleasant feeling in my body; it became so intense that I had to sit down. I went to the pharmacy counter to alert staff. It was followed by excruciating muscle spasms in my lower back/upper pelvic area. When the staff came out (after second request), they asked if I wanted to call for paramedics; I decided to wait for a few minutes, with someone monitoring me, to see if it improved. Within 20 -30 minutes, I felt well enough to leave. I took Tylenol and ibuprofen (alternately) for several days and rested while I had the usual symptoms - fatigue, muscle aches....  Friday (14th?) I noticed a rash on both upper thighs on the inside and top; I had also had sharp pains in one index finger joint the night before. I made an appointment with my physician. It did not match the rash on my arm.  The following Friday I had an attack of diarrhea, followed by gastrointestinal symptoms that lasted for several days. ( I saw my physician about that, too.)
Low grade fever (100.6F) and chills, nausea, vomiting and malaise
mom reported 10JAN97 pt had high pitched crying for 3 days;mom did not call MD office to report prior to this;but pt was very fussy & would only calm down to nurse or nap for a short time;
Nine days after vaccination, presented to coast guard clinic with 2 days of worsening fever, headache and myalgia.  Also had evidence of autoinoculation - back, rt cheek, and chest. Sent to Hospital. Eye exam normal, observed with improvement in system symptoms and no progression of skin lesion. Ongoing improvement. He required such a prolonged hospital stay due to non compliance with core and transmission risk to his family with 2 small children. He has fully recovered.
My lower back started to hurt, 102 fever, body aches, and chills. The next morning I was weak no appetite and very light headed and couldn't concentrate. I go days with muscles weakness in my body since the shot.
Rhinorrhea, nasal congestion, red/flushed face, generalized rash, low grade fever, fatigue and joint pain.
Transaminitis (elevated liver enzymes), fatigue. ALT 110. AST 52. symptoms lasted around 6 months and resolved with time.
Patient was given vaccines on 09/23/2019. Patient was given Dtap/IPV and Varcella in the left thy.  Patient presented to the clinic  on 09/25/2019 with a noted swelling, redness, and tenderness the sizes of the palm  around were the vaccines were given on the left thy.  Provider instructed the patients parents to apply warm compresses , Tylenol and antihistamines .
This spontaneous report as received from the certified medical assistant (healthcare worker) refers to a patient of unknown age and gender. On 26-NOV-2014 improperly stored GARDASIL (lot # K004205, expiration date 12-JAN-2017, dose and frequency not reported) was administered to the patient. No adverse events were reported. No further information was provided. This is one of several reports from the same source. Additional information has been requested.
This spontaneous report as received from a shareholder of Merck refers to a young female patient of unknown age which was his friend's daughter. On an unknown date the patient was vaccinated with an unspecified HPV vaccine (manufacturer unknown) (lot #, dose not provided). On an unknown date the patient experienced severe side effects from the vaccination. The patient was in such bad shape that there was no way that she can even return to school. The outcome of side effects was unknown. Upon internal review, the event was considered to be disabling since the patient could not return to school due to the event. Additional information has been requested.
The pt experienced flu symptoms, shortness of breath, chest congestion, runny nose, constant cough, muscle aches etc. Still very sick.
0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr., Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. Patient did not have any adverse reactions.
sore arm couldn't lift it or want to move it started to get warm & irritable-couldn't sleep; gave Motrin; (4AM crying-fidgity, t101.5, face swollen on lt side); pt taken to ER in late AM;
This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date between 06-APR-2017 and 01-MAY-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # M016193, expiration date 24-APR-2018, intramuscularly (dose was not reported) in immunization series. There were no adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 34.5 degrees Fahrenheit for 1 hour and 53 minutes and of 34.7 degrees Fahrenheit for 1 hour and 25 minutes. There were no previous temperature excursions reported. A Digital Data Logger was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA000781: US-009507513-1705USA007705: US-009507513-1705USA007706: US-009507513-1705USA007707: US-009507513-1705USA007708: US-009507513-1705USA007709: US-009507513-1705USA007710: US-009507513-1705USA007712.
Patient received the Covid-19 vaccine. He reports symptoms of Other: Dizziness. I have observed Patient as he reports signs of dizziness while in the observation area, about 15 min after vaccine.  Moderna Lot # 023M20A  Denies c/o itching, difficulty swallowing, breathing, nausea or SOB.  Color is pink, speaking clearly, alert and oriented.  States he worked all night at this job, has not eaten breakfast and came straight from work to receive the covid vaccine. Left deltoid area without reaction type symptoms, no redness, warmth, swelling or bleeding.   Treatment/intervention  -  Vital signs as noted:  0948am SBP - 132/96, HR 65 sinus, RR 20, SPO2 99% Pt Placed on cot, laying supine. Dizziness remains. Water provided. 1000am SBP - 128/92, HR 68 sinus, RR18, SPo2 98%  Additional water and fruit snacks provided. Taking well PO. Remains on cot, head of bed elevated, dizziness less then earlier. 1020am -SBP -126/94, HR 78 sinus, RR 18, SPO2 98% Pt Sitting at edge of bed, denies dizziness at this time.  No complaints.   1030 - Standing, no complaints.  Pt monitored for 30 minutes. Gait steady as walking to leave facility. Advised if any concerns or issues arise to seek medical attention if needed. Verbalized understanding. Also recommended to reach out to PCP for follow-up for SBP results today. RN
MATERNAL EXPOSURE DURING PREGNANCY; FEELING UNWELL; CHILLS; MUSCLE PAIN; HEADACHE; FEVER 100 FAHRENHEIT (°F); FATIGUE; .This solicited pregnancy report received from a consumer concerned a 30 year old female.  The patient was enrolled in a study. The patient's weight was 56.59 kilograms, and height was not reported. The patient's concurrent conditions included alcohol use. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included loratadine, and minerals nos/vitamins nos. On 06-APR-2021, the patient experienced maternal exposure during pregnancy. On 06-APR-2021, the patient experienced feeling unwell. On 06-APR-2021, the patient experienced chills. On 06-APR-2021, the patient experienced muscle pain. On 06-APR-2021, the patient experienced headache. On 06-APR-2021, the patient experienced fever 100 fahrenheit (°f). On 06-APR-2021, the patient experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 100 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle pain, headache, fever 100 fahrenheit (°f), feeling unwell, chills, maternal exposure during pregnancy and fatigue was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and maternal exposure during pregnancy was not related, and between covid-19 vaccine ad26.cov2.s, and feeling unwell, chills, muscle pain, headache, fever 100 fahrenheit (°f), and fatigue was related.  This report was non-serious.; Sender's Comments: V0; Medical assessment comment not required as per standard procedure as case assessed as non-serious.